Sentio 286202200
Sentio 286202200 is a Class II device made by Medos International Sàrl, cleared under FDA 510(k) K173526 on 5 Apr 2018 and listed in FDA GUDID since 8 Oct 2018 (UDI-DI 10705034534763), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10705034534763 | Date8 Oct 2018 | StatusListed |
| United States | FDA 510(k)SESE | NumberK173526 | Date5 Apr 2018 | StatusActive |
Official records
- AccessGUDID record 10705034534763
- FDA 510(k) database K173526
Across registries
- FDA 510(k) K173526 decided 5 Apr 2018 Active
- FDA GUDID UDI-DI 10705034534763 listed 8 Oct 2018 Listed
Timeline
- Cleared FDA 510(k) K173526
- Listed FDA GUDID 10705034534763
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Sentio
- Generic name
- Nerve-locating system probe, single-use
- Model / Ref / Catalog
- 286202200
- Primary DI / UDI-DI
- 10705034534763
- 510(k) Number
- FDA product code
- ETN, PDQ
- GMDN term
- Nerve-locating system probe, single-use
- Device class
- Class II
- Regulation number
- 874.1820
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Nerve-locating system probe, single-use.